MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway
2003 · Oncogene · 91 citations
https://doi.org/10.1038/sj.onc.1206378
T
Takeshi Shiraishi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
119
Papers
2.3K
Citations
25
h-index
37
i10-index
Takeshi Shiraishi is an academic researcher from Matsuyama Red Cross Hospital. The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Cancer Immunotherapy and Biomarkers & Colorectal Cancer Treatments and Studies. The author has an h-index of 25, co-authored 102 publications.
ORCID: 0000-0001-9558-3576Papers by this author
worksMulticenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC-06)
2017 · Gastric Cancer · 26 citations
https://doi.org/10.1007/s10120-017-0766-x
Study protocol and baseline characteristics of newly induced dialysis patients: a prospective multi-center cohort study with a biological sample bank, the Ibaraki Dialysis Initiation Cohort (iDIC) study
2022 · BMC Nephrology · 3 citations
https://doi.org/10.1186/s12882-022-02729-3
Importance of diagnosis and initial treatment strategy for adenosquamous carcinoma of the tongue: A case report and literature review
2017 · Oral and Maxillofacial Surgery Cases · 1 citations
https://doi.org/10.1016/j.omsc.2017.08.003
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat